Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]

View source ↗

Summary

Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute myeloid leukemia, chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Castration-resistant Prostate Cancer
• Chronic Lymphocytic Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma
• Solid Tumors

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | Status: ENROLLING_BY_INVITATION